MedPath

Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41
Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .

Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions
Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture
Associated Therapies
Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Effects of Vitamin D Supplementation in Obesity

Phase 4
Completed
Conditions
Vitamin D Deficiency
Obesity
Interventions
First Posted Date
2009-12-21
Last Posted Date
2012-08-02
Lead Sponsor
University of Aarhus
Target Recruit Count
55
Registration Number
NCT01037140
Locations
🇩🇰

Dept. of Endocrinology and Metabolism, Aarhus University Hospital, Aarhus, Denmark

Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect of Supplementation on Insulin Requirements

Phase 3
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
First Posted Date
2009-12-10
Last Posted Date
2017-04-17
Lead Sponsor
William Beaumont Hospitals
Target Recruit Count
75
Registration Number
NCT01029392
Locations
🇺🇸

WilliamBH, Royal Oak, Michigan, United States

The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease

Phase 3
Completed
Conditions
Proteinuria
Chronic Renal Insufficiency
Interventions
Other: Placebo
Drug: Vitamin D
First Posted Date
2009-12-09
Last Posted Date
2023-08-16
Lead Sponsor
Albert Einstein College of Medicine
Target Recruit Count
74
Registration Number
NCT01029002
Locations
🇺🇸

Montefiore medical center, Bronx, New York, United States

Safety and Immunologic Effect of Low Dose Versus High Dose Vitamin D3 in Multiple Sclerosis

Phase 1
Completed
Conditions
Multiple Sclerosis
Vitamin D Deficiency
Interventions
First Posted Date
2009-12-03
Last Posted Date
2013-02-06
Lead Sponsor
Johns Hopkins University
Target Recruit Count
40
Registration Number
NCT01024777
Locations
🇺🇸

Johns Hopkins University, Baltimore, Maryland, United States

Vitamin D Treatment to Patients Suffering From Chronic Pain and Vitamin D Hypovitaminosis

Not Applicable
Completed
Conditions
Back Pain
Hypovitaminosis D
Interventions
Drug: Vitamin D
Drug: Placebo
First Posted Date
2009-12-02
Last Posted Date
2012-10-16
Lead Sponsor
Tel-Aviv Sourasky Medical Center
Target Recruit Count
12
Registration Number
NCT01023490
Locations
🇮🇱

Tel Aviv Sourasky Medical Center, Pain Medicine Unit, Tel Aviv, Israel

Vitamin D, C-reactive Protein and Insulin Resistance

Phase 3
Completed
Conditions
Diabetes
Low-intensity Chronic Inflammation
Insulin Resistance
Interventions
First Posted Date
2009-11-25
Last Posted Date
2009-11-25
Lead Sponsor
Instituto Nacional de Salud Publica, Mexico
Target Recruit Count
104
Registration Number
NCT01019642
Locations
🇲🇽

Instituto Mexicano del Seguro Social, Cuernavaca, Morelos, Mexico

MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)

Phase 2
Completed
Conditions
Postmenopausal Osteoporosis
Osteoporosis
Interventions
Drug: Placebo to MK-5442
Drug: MK-5442
Drug: Alendronate Sodium
Drug: Vitamin D3
Drug: Calcium carbonate
Drug: Placebo to Alendronate
First Posted Date
2009-10-16
Last Posted Date
2016-01-22
Lead Sponsor
Merck Sharp & Dohme LLC
Target Recruit Count
526
Registration Number
NCT00996801

Vitamin D Supplementation Requirement in Obese Subjects

Not Applicable
Terminated
Conditions
Vitamin D Deficiency
Interventions
Drug: placebo
Drug: Vitamin D3
First Posted Date
2009-10-16
Last Posted Date
2023-07-03
Lead Sponsor
Winthrop University Hospital
Target Recruit Count
27
Registration Number
NCT00996866
Locations
🇺🇸

Winthrop University Hospital, Mineola, New York, United States

Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity

Phase 2
Conditions
Diabetes Mellitus Type 2
Hypovitaminosis D
Interventions
Other: Orange juice
Drug: Cholecalciferol
First Posted Date
2009-10-09
Last Posted Date
2009-11-03
Lead Sponsor
University Hospital, Aker
Target Recruit Count
60
Registration Number
NCT00992797
Locations
🇳🇴

Diabetes Laboratory, Oslo University Hospital Aker, Oslo, Norway

Study of Vitamin D Supplementation to Male HIV Sero-positive Patients

Not Applicable
Completed
Conditions
HIV Seropositive
Interventions
First Posted Date
2009-10-07
Last Posted Date
2012-09-17
Lead Sponsor
Hvidovre University Hospital
Target Recruit Count
60
Registration Number
NCT00990678
Locations
🇩🇰

Dept. of endocrinology, Hvidovre Hospital, Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath